Everest Medicines

Everest Medicines is a biopharmaceutical company focused on late-stage clinical development, dedicated to in-licensing, developing, and commercializing innovative therapies globally. Its mission is to address unmet medical needs in Greater China and other emerging Asia-Pacific markets. With a world-class clinical and regulatory team, visionary business development drive, and an integrated commercial platform, these strengths enable the company to continuously accelerate patient access to innovative drugs.Since its establishment in 2017, the company has built a portfolio of eight promising clinical-stage drug candidates across oncology, immunology, cardiorenal, and infectious diseases. The company focuses on these four therapeutic areas based on the severity of unmet medical needs, the size of the potential patient population, and the availability of globally innovative products.